Hugo Murua Escobar - Search Results

Year	Number of Results
2003	1
2004	4
2005	3
2006	3
2007	2
2008	5
2009	3
2010	1
2011	3
2012	4
2013	7
2014	7
2015	11
2016	13
2017	8
2018	5
2019	7
2020	18
2021	10
2022	20
2023	9
2024	3

1

Comparative Analyses of Targeted Myeloid Cancer Next-Generation Sequencing Panel in Fresh Blood, Bone Marrow and FFPE Material.

Hobeck AD, Wendt S, Krohn S, Knuebel G, Bartels S, Schipper E, Junghanss C, Murua Escobar H. Hobeck AD, et al. Among authors: murua escobar h. Int J Mol Sci. 2024 Mar 21;25(6):3534. doi: 10.3390/ijms25063534. Int J Mol Sci. 2024. PMID: 38542506 Free PMC article.

2

Cross-Species Comparison of the Pan-RAF Inhibitor LY3009120's Anti-Tumor Effects in Equine, Canine, and Human Malignant Melanoma Cell Lines.

Gao Y, Packeiser EM, Wendt S, Sekora A, Cavalleri JV, Pratscher B, Alammar M, Hühns M, Brenig B, Junghanss C, Nolte I, Murua Escobar H. Gao Y, et al. Among authors: murua escobar h. Genes (Basel). 2024 Feb 3;15(2):202. doi: 10.3390/genes15020202. Genes (Basel). 2024. PMID: 38397192 Free PMC article.

3

Abdominal venous thromboses: detection of the JAK2 p.V617F mutation by next-generation ultradeep sequencing-A prevalence study of patients in Mecklenburg-West Pomerania (2017-2021).

Henze L, Grunwald L, Felser S, Witte M, Grosse-Thie C, Roolf C, Murua Escobar H, Junghanss C. Henze L, et al. Among authors: murua escobar h. Front Med (Lausanne). 2024 Jan 11;10:1344769. doi: 10.3389/fmed.2023.1344769. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38274463 Free PMC article.

4

The TiHoCL panel for canine lymphoma: a feasibility study integrating functional genomics and network biology approaches for comparative oncology targeted NGS panel design.

Fibi-Smetana S, Inglis C, Schuster D, Eberle N, Granados-Soler JL, Liu W, Krohn S, Junghanss C, Nolte I, Taher L, Murua Escobar H. Fibi-Smetana S, et al. Among authors: murua escobar h. Front Vet Sci. 2023 Dec 8;10:1301536. doi: 10.3389/fvets.2023.1301536. eCollection 2023. Front Vet Sci. 2023. PMID: 38144469 Free PMC article.

5

Exploring Thiazolopyridine AV25R: Unraveling of Biological Activities, Selective Anti-Cancer Properties and In Silico Target and Binding Prediction in Hematological Neoplasms.

Ladwig A, Gupta S, Ehlers P, Sekora A, Alammar M, Koczan D, Wolkenhauer O, Junghanss C, Langer P, Murua Escobar H. Ladwig A, et al. Among authors: murua escobar h. Molecules. 2023 Dec 15;28(24):8120. doi: 10.3390/molecules28248120. Molecules. 2023. PMID: 38138609 Free PMC article.

6

Generation of the human iPSC lines AKOSi011-A carrying the mutation p.Pro65Ser/p.Asp35T and AKOSi012-A, carrying the mutation p.Tyr231His, derived from FAHN patient fibroblasts.

Efendic F, Krohn S, Murua Escobar H, Venkateswaran S, Bennett SAL, Hermann A, Frech MJ. Efendic F, et al. Among authors: murua escobar h. Stem Cell Res. 2023 Sep;71:103178. doi: 10.1016/j.scr.2023.103178. Epub 2023 Aug 9. Stem Cell Res. 2023. PMID: 37573804 Free article.

7

MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines.

Packeiser EM, Engels L, Nolte I, Goericke-Pesch S, Murua Escobar H. Packeiser EM, et al. Among authors: murua escobar h. Int J Mol Sci. 2023 May 2;24(9):8136. doi: 10.3390/ijms24098136. Int J Mol Sci. 2023. PMID: 37175843 Free PMC article.

8

Immunogenic cell death triggered by impaired deubiquitination in multiple myeloma relies on dysregulated type I interferon signaling.

Waad Sadiq Z, Brioli A, Al-Abdulla R, Çetin G, Schütt J, Murua Escobar H, Krüger E, Ebstein F. Waad Sadiq Z, et al. Among authors: murua escobar h. Front Immunol. 2023 Mar 2;14:982720. doi: 10.3389/fimmu.2023.982720. eCollection 2023. Front Immunol. 2023. PMID: 36936919 Free PMC article.

9

Combined BCL-2 and PI3K/AKT Pathway Inhibition in KMT2A-Rearranged Acute B-Lymphoblastic Leukemia Cells.

Holz C, Lange S, Sekora A, Knuebel G, Krohn S, Murua Escobar H, Junghanss C, Richter A. Holz C, et al. Among authors: murua escobar h. Int J Mol Sci. 2023 Jan 10;24(2):1359. doi: 10.3390/ijms24021359. Int J Mol Sci. 2023. PMID: 36674872 Free PMC article.

10

Uncoupling protein 2 deficiency of non-cancerous tissues inhibits the progression of pancreatic cancer in mice.

Revskij D, Runst J, Umstätter C, Ehlers L, Rohde S, Zechner D, Bastian M, Müller-Hilke B, Fuellen G, Henze L, Murua Escobar H, Junghanss C, Kowald A, Walter U, Köhling R, Wolkenhauer O, Jaster R. Revskij D, et al. Among authors: murua escobar h. Hepatobiliary Pancreat Dis Int. 2023 Apr;22(2):190-199. doi: 10.1016/j.hbpd.2022.12.003. Epub 2022 Dec 14. Hepatobiliary Pancreat Dis Int. 2023. PMID: 36549966

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

135 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year